The invention relates to compounds of formula (I), wherein R1a -R1e, R2a, R2b,R3 and R5 are as defined in the first claim. Said compounds are tyrosine-kinase inhibitors, in particular TIE-2 and Raf kinases which can be used, inparticular for treating malignant tumors.